Vassilios James Bezzerides, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tachycardia, Supraventricular | 4 | 2020 | 237 | 1.580 |
Why?
|
| Arrhythmias, Cardiac | 7 | 2022 | 2140 | 1.500 |
Why?
|
| Wolff-Parkinson-White Syndrome | 2 | 2019 | 102 | 1.320 |
Why?
|
| Myocytes, Cardiac | 13 | 2020 | 1645 | 1.290 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 3 | 2021 | 181 | 1.080 |
Why?
|
| Tachycardia, Ventricular | 6 | 2020 | 1217 | 0.940 |
Why?
|
| Ventricular Fibrillation | 2 | 2021 | 535 | 0.830 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 2020 | 592 | 0.730 |
Why?
|
| Pre-Excitation Syndromes | 1 | 2019 | 23 | 0.730 |
Why?
|
| Personnel Selection | 1 | 2020 | 195 | 0.680 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2020 | 470 | 0.650 |
Why?
|
| Induced Pluripotent Stem Cells | 5 | 2020 | 1604 | 0.580 |
Why?
|
| Electrocardiography | 7 | 2020 | 6409 | 0.580 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2017 | 328 | 0.580 |
Why?
|
| Research Personnel | 1 | 2020 | 520 | 0.560 |
Why?
|
| Action Potentials | 4 | 2020 | 1791 | 0.540 |
Why?
|
| Models, Cardiovascular | 2 | 2016 | 1005 | 0.510 |
Why?
|
| Immediate-Early Proteins | 1 | 2017 | 457 | 0.510 |
Why?
|
| Heart Defects, Congenital | 3 | 2020 | 4267 | 0.500 |
Why?
|
| Career Choice | 1 | 2020 | 746 | 0.500 |
Why?
|
| Catheter Ablation | 3 | 2022 | 2563 | 0.430 |
Why?
|
| Physical Conditioning, Animal | 2 | 2015 | 374 | 0.430 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2011 | 64 | 0.430 |
Why?
|
| Nitroso Compounds | 1 | 2011 | 70 | 0.430 |
Why?
|
| Thromboembolism | 1 | 2017 | 986 | 0.420 |
Why?
|
| Nitrites | 1 | 2011 | 168 | 0.410 |
Why?
|
| Barth Syndrome | 2 | 2021 | 26 | 0.400 |
Why?
|
| Heart Rate | 2 | 2020 | 4100 | 0.370 |
Why?
|
| Thrombolytic Therapy | 1 | 2017 | 2182 | 0.330 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2011 | 497 | 0.320 |
Why?
|
| Atrial Fibrillation | 2 | 2021 | 4531 | 0.290 |
Why?
|
| Biomedical Research | 1 | 2020 | 3273 | 0.260 |
Why?
|
| Transport Vesicles | 1 | 2004 | 89 | 0.250 |
Why?
|
| Plakophilins | 1 | 2022 | 34 | 0.230 |
Why?
|
| Nitric Oxide | 1 | 2011 | 2127 | 0.220 |
Why?
|
| Heart Conduction System | 2 | 2018 | 1032 | 0.220 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 2022 | 132 | 0.210 |
Why?
|
| Reactive Oxygen Species | 2 | 2021 | 2147 | 0.210 |
Why?
|
| Atrioventricular Block | 1 | 2022 | 111 | 0.200 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2022 | 161 | 0.200 |
Why?
|
| Accessory Atrioventricular Bundle | 1 | 2020 | 46 | 0.200 |
Why?
|
| Calcium Channels | 1 | 2004 | 657 | 0.190 |
Why?
|
| Sotalol | 1 | 2020 | 45 | 0.190 |
Why?
|
| Heart Rate, Fetal | 1 | 2020 | 75 | 0.190 |
Why?
|
| Telemetry | 1 | 2020 | 196 | 0.180 |
Why?
|
| Naphthyridines | 1 | 2019 | 120 | 0.180 |
Why?
|
| Cells, Cultured | 8 | 2020 | 20095 | 0.180 |
Why?
|
| Mixed Function Oxygenases | 1 | 2020 | 316 | 0.180 |
Why?
|
| Channelopathies | 1 | 2018 | 27 | 0.180 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2020 | 766 | 0.170 |
Why?
|
| Activin Receptors, Type II | 1 | 2019 | 110 | 0.170 |
Why?
|
| Fetal Heart | 1 | 2020 | 274 | 0.170 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2018 | 76 | 0.170 |
Why?
|
| Animals, Newborn | 3 | 2019 | 2858 | 0.170 |
Why?
|
| Death, Sudden | 1 | 2018 | 314 | 0.150 |
Why?
|
| Injections, Subcutaneous | 1 | 2017 | 688 | 0.150 |
Why?
|
| Retrospective Studies | 11 | 2022 | 72614 | 0.150 |
Why?
|
| Myocardium | 2 | 2020 | 4943 | 0.150 |
Why?
|
| Bundle-Branch Block | 1 | 2018 | 276 | 0.140 |
Why?
|
| Mitochondria, Heart | 1 | 2017 | 262 | 0.140 |
Why?
|
| S100 Proteins | 1 | 2016 | 262 | 0.140 |
Why?
|
| Syncope | 1 | 2019 | 434 | 0.140 |
Why?
|
| Radio Waves | 1 | 2016 | 249 | 0.140 |
Why?
|
| Adolescent | 12 | 2020 | 85139 | 0.140 |
Why?
|
| STAT1 Transcription Factor | 1 | 2016 | 326 | 0.140 |
Why?
|
| Postoperative Complications | 1 | 2017 | 15126 | 0.140 |
Why?
|
| Bandages | 1 | 2016 | 261 | 0.130 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2020 | 1410 | 0.130 |
Why?
|
| Exercise | 1 | 2011 | 5330 | 0.130 |
Why?
|
| Adenoviridae | 1 | 2019 | 1133 | 0.130 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 1211 | 0.130 |
Why?
|
| Dependovirus | 1 | 2020 | 741 | 0.130 |
Why?
|
| Fetal Diseases | 1 | 2020 | 900 | 0.130 |
Why?
|
| Humans | 34 | 2022 | 717237 | 0.130 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2020 | 863 | 0.130 |
Why?
|
| Animals | 15 | 2021 | 170890 | 0.130 |
Why?
|
| Cell Proliferation | 4 | 2017 | 10802 | 0.120 |
Why?
|
| Postoperative Care | 1 | 2020 | 1512 | 0.120 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2020 | 2117 | 0.120 |
Why?
|
| Long QT Syndrome | 1 | 2017 | 421 | 0.120 |
Why?
|
| Protein Interaction Mapping | 1 | 2017 | 642 | 0.120 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2018 | 501 | 0.110 |
Why?
|
| Infusions, Intravenous | 1 | 2017 | 2298 | 0.110 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2016 | 846 | 0.110 |
Why?
|
| Fontan Procedure | 1 | 2018 | 741 | 0.110 |
Why?
|
| Heart | 2 | 2016 | 4332 | 0.110 |
Why?
|
| Foreign Bodies | 1 | 2016 | 400 | 0.110 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 993 | 0.110 |
Why?
|
| Child | 11 | 2022 | 74387 | 0.110 |
Why?
|
| Child, Preschool | 9 | 2020 | 41221 | 0.110 |
Why?
|
| Ventricular Remodeling | 1 | 2020 | 1273 | 0.110 |
Why?
|
| Heart Ventricles | 3 | 2019 | 3837 | 0.110 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2020 | 1196 | 0.110 |
Why?
|
| Sports | 1 | 2017 | 651 | 0.110 |
Why?
|
| Pacemaker, Artificial | 1 | 2016 | 768 | 0.110 |
Why?
|
| Prostheses and Implants | 1 | 2019 | 1346 | 0.100 |
Why?
|
| Male | 19 | 2020 | 351380 | 0.100 |
Why?
|
| Mutation, Missense | 1 | 2020 | 2511 | 0.100 |
Why?
|
| Drosophila Proteins | 1 | 2020 | 1768 | 0.100 |
Why?
|
| Mice, Knockout | 5 | 2021 | 15258 | 0.100 |
Why?
|
| Cardiomegaly | 1 | 2014 | 650 | 0.100 |
Why?
|
| Heart Arrest | 1 | 2020 | 1374 | 0.100 |
Why?
|
| Phenotype | 4 | 2020 | 16404 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2018 | 1762 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 2791 | 0.090 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 9927 | 0.090 |
Why?
|
| Cardiology | 1 | 2020 | 1652 | 0.090 |
Why?
|
| Heart Failure | 4 | 2020 | 10185 | 0.090 |
Why?
|
| Signal Transduction | 6 | 2020 | 23996 | 0.090 |
Why?
|
| Tissue Engineering | 1 | 2019 | 1855 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 2972 | 0.090 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 18352 | 0.090 |
Why?
|
| Transcription Factors | 2 | 2020 | 12073 | 0.090 |
Why?
|
| Activities of Daily Living | 1 | 2017 | 2323 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2011 | 720 | 0.080 |
Why?
|
| Reperfusion Injury | 1 | 2015 | 1074 | 0.080 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 2210 | 0.080 |
Why?
|
| Feasibility Studies | 1 | 2017 | 4921 | 0.080 |
Why?
|
| Cell Cycle | 1 | 2016 | 3022 | 0.080 |
Why?
|
| Female | 15 | 2020 | 377909 | 0.080 |
Why?
|
| Calcium | 1 | 2021 | 5832 | 0.080 |
Why?
|
| Cell Cycle Proteins | 2 | 2016 | 3511 | 0.080 |
Why?
|
| Ventricular Function, Left | 1 | 2020 | 3433 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2016 | 2555 | 0.080 |
Why?
|
| Mice | 7 | 2021 | 81126 | 0.080 |
Why?
|
| Length of Stay | 1 | 2020 | 6280 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2020 | 5135 | 0.070 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2 | 2019 | 131 | 0.070 |
Why?
|
| Cardiomyopathies | 1 | 2017 | 1831 | 0.070 |
Why?
|
| Infant | 4 | 2020 | 34574 | 0.070 |
Why?
|
| Incidence | 3 | 2020 | 20653 | 0.070 |
Why?
|
| Zebrafish | 1 | 2017 | 3030 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 3008 | 0.070 |
Why?
|
| Pediatrics | 1 | 2020 | 3556 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 11276 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2011 | 3873 | 0.070 |
Why?
|
| Chromones | 1 | 2004 | 165 | 0.070 |
Why?
|
| Massachusetts | 1 | 2017 | 8749 | 0.060 |
Why?
|
| Microscopy, Confocal | 2 | 2015 | 2043 | 0.060 |
Why?
|
| TRPC Cation Channels | 1 | 2004 | 118 | 0.060 |
Why?
|
| Electric Conductivity | 1 | 2004 | 434 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2020 | 24742 | 0.060 |
Why?
|
| MicroRNAs | 2 | 2020 | 3680 | 0.060 |
Why?
|
| Cell Membrane | 2 | 2004 | 3918 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2016 | 3433 | 0.060 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2004 | 250 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2019 | 6664 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 13274 | 0.060 |
Why?
|
| Time Factors | 5 | 2020 | 41095 | 0.060 |
Why?
|
| Androstadienes | 1 | 2004 | 343 | 0.060 |
Why?
|
| Aging | 2 | 2019 | 8376 | 0.060 |
Why?
|
| Exocytosis | 1 | 2004 | 362 | 0.060 |
Why?
|
| Cell Line | 3 | 2020 | 16693 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2017 | 4373 | 0.060 |
Why?
|
| Neurites | 1 | 2004 | 391 | 0.060 |
Why?
|
| Young Adult | 5 | 2020 | 56247 | 0.060 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3160 | 0.050 |
Why?
|
| Treatment Outcome | 4 | 2022 | 62348 | 0.050 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2004 | 448 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 39302 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3278 | 0.050 |
Why?
|
| Cation Transport Proteins | 1 | 2004 | 332 | 0.050 |
Why?
|
| Patch-Clamp Techniques | 1 | 2004 | 979 | 0.050 |
Why?
|
| Eukaryotic Cells | 1 | 2003 | 210 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2020 | 17432 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 3469 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 887 | 0.050 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 726 | 0.050 |
Why?
|
| Morpholines | 1 | 2004 | 572 | 0.050 |
Why?
|
| Echocardiography | 3 | 2020 | 5099 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2019 | 21805 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 7292 | 0.050 |
Why?
|
| Adult | 8 | 2020 | 212451 | 0.050 |
Why?
|
| Rats | 4 | 2020 | 25091 | 0.050 |
Why?
|
| Toluene | 1 | 2019 | 44 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 5495 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 12433 | 0.050 |
Why?
|
| Recurrence | 2 | 2022 | 8282 | 0.050 |
Why?
|
| Follistatin-Related Proteins | 1 | 2019 | 54 | 0.050 |
Why?
|
| Desmoplakins | 1 | 2019 | 66 | 0.050 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2019 | 99 | 0.040 |
Why?
|
| Benzothiazoles | 1 | 2019 | 254 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 2003 | 973 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2014 | 13301 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2004 | 2198 | 0.040 |
Why?
|
| Fetal Death | 1 | 2020 | 457 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2003 | 1278 | 0.040 |
Why?
|
| Activins | 1 | 2019 | 228 | 0.040 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2020 | 455 | 0.040 |
Why?
|
| Protein Transport | 1 | 2003 | 2066 | 0.040 |
Why?
|
| Heart Block | 1 | 2018 | 407 | 0.040 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2016 | 38 | 0.040 |
Why?
|
| Genetics, Population | 1 | 2022 | 991 | 0.040 |
Why?
|
| Genetic Testing | 2 | 2020 | 3340 | 0.040 |
Why?
|
| Mutation | 2 | 2020 | 29491 | 0.040 |
Why?
|
| Systole | 1 | 2019 | 993 | 0.040 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2016 | 74 | 0.040 |
Why?
|
| Kinetics | 1 | 2004 | 6805 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2004 | 5438 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2019 | 1048 | 0.030 |
Why?
|
| Pressure | 1 | 2019 | 1240 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2020 | 1836 | 0.030 |
Why?
|
| Cell Enlargement | 1 | 2015 | 60 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2016 | 455 | 0.030 |
Why?
|
| Protein Stability | 1 | 2016 | 572 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 2336 | 0.030 |
Why?
|
| Heart Atria | 1 | 2020 | 1273 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2004 | 2961 | 0.030 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2014 | 100 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2014 | 104 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2016 | 8600 | 0.030 |
Why?
|
| Acetylation | 1 | 2016 | 1121 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 14381 | 0.030 |
Why?
|
| Neuregulin-1 | 1 | 2014 | 141 | 0.030 |
Why?
|
| Vascular System Injuries | 1 | 2016 | 216 | 0.030 |
Why?
|
| Prevalence | 2 | 2022 | 14896 | 0.030 |
Why?
|
| Fibrosis | 1 | 2020 | 1964 | 0.030 |
Why?
|
| Antigens, Differentiation | 1 | 2016 | 967 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 2918 | 0.030 |
Why?
|
| Risk Factors | 4 | 2020 | 70864 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 3933 | 0.030 |
Why?
|
| Cell Shape | 1 | 2014 | 379 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2014 | 297 | 0.030 |
Why?
|
| Imidazoles | 1 | 2019 | 1273 | 0.030 |
Why?
|
| Cell Communication | 1 | 2020 | 1657 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2016 | 2022 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2020 | 1600 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2019 | 1472 | 0.030 |
Why?
|
| Ligands | 1 | 2019 | 3334 | 0.030 |
Why?
|
| Hippocampus | 1 | 2004 | 3660 | 0.030 |
Why?
|
| Gestational Age | 1 | 2020 | 3427 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2020 | 1779 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 22929 | 0.030 |
Why?
|
| Angiotensin II | 1 | 2014 | 921 | 0.020 |
Why?
|
| Models, Biological | 2 | 2004 | 9892 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2016 | 1616 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2020 | 4286 | 0.020 |
Why?
|
| Piperazines | 1 | 2019 | 2543 | 0.020 |
Why?
|
| Kidney | 1 | 2004 | 6910 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 9532 | 0.020 |
Why?
|
| Protein Binding | 2 | 2016 | 9665 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2020 | 23542 | 0.020 |
Why?
|
| Transfection | 1 | 2016 | 6142 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 1730 | 0.020 |
Why?
|
| DNA Damage | 1 | 2017 | 2470 | 0.020 |
Why?
|
| RNA Interference | 1 | 2016 | 3020 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2016 | 3512 | 0.020 |
Why?
|
| Neurons | 1 | 2004 | 9441 | 0.020 |
Why?
|
| Boston | 1 | 2018 | 9407 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2016 | 14243 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 15271 | 0.020 |
Why?
|
| Computational Biology | 1 | 2016 | 3568 | 0.020 |
Why?
|
| Cholinergic Agonists | 1 | 2003 | 71 | 0.020 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2003 | 95 | 0.010 |
Why?
|
| Diglycerides | 1 | 2003 | 182 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2020 | 11758 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2003 | 134 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 4480 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18798 | 0.010 |
Why?
|
| United States | 2 | 2020 | 67798 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 11777 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 16017 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29226 | 0.010 |
Why?
|
| Hormones | 1 | 2003 | 857 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 9804 | 0.010 |
Why?
|
| Pregnancy | 1 | 2020 | 27306 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 1711 | 0.010 |
Why?
|
| Reaction Time | 1 | 2003 | 2138 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 3991 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 3874 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 58528 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 162856 | 0.000 |
Why?
|
| Middle Aged | 1 | 2019 | 215041 | 0.000 |
Why?
|